Prognostic Value of Circulating Tumor DNA-Based Minimal Residual Disease for Recurrence-Free Survival in Resectable Gastric Cancer: A Systematic Review and Meta-Analysis with Serial Monitoring Analysis.

Dig Dis SciJun 3, 2026 (epub)
Clinical ResearchOncology (Medical)GastroenterologyOpen access

Abdul Ahad Mehboob, Abdul Ghani Iqbal, Tooba Shaukat Butt et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review and meta-analysis evaluated the prognostic value of circulating tumor DNA (ctDNA)-based minimal residual disease (MRD) in 520 patients with resectable gastric cancer. The study found that postoperative ctDNA positivity was significantly associated with reduced recurrence-free survival (RFS: HR 12.26) and overall survival (OS: HR 8.57), indicating its potential as a biomarker in this population.

Key findings

  • Postoperative ctDNA positivity was linked to a 12.26-fold increase in risk of recurrence-free survival.
  • Overall survival was adversely affected with a hazard ratio of 8.57 for ctDNA positivity.
  • Postoperative ctDNA detection had a stronger prognostic value (HR 10.00) compared to preoperative assessment (HR 2.17).
  • Substantial heterogeneity was noted among studies, with I² values ranging from 65-72%.

Why it matters

Understanding the prognostic implications of ctDNA in resectable gastric cancer can help clinicians identify high-risk patients who may benefit from closer monitoring or additional therapeutic strategies, although its clinical utility is not yet established.

What to keep in mind

The analysis is limited by the small number of studies and substantial heterogeneity in ctDNA assay characteristics and postoperative sampling timing.

Source

PubMed · PMID 42236991Free full text on PubMed Central

Published in Dig Dis Sci. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Oncology (Medical)

Clinical ResearchPreventive Medicine / Public Health

2025 National Guidelines on the Mediterranean Diet: Executive Summary of a Joint Report by Italian Scientific Societies and the National Institute of Health Task Force on Clinical Practice Guidelines.

This systematic review and practice guideline, developed by a multidisciplinary panel using NUTRIGRADE, assessed Mediterranean diet evidence across nine health domains and one economic domain.

Nutr RevNov 12, 2026Read summary
Clinical ResearchOrthopedic Surgery

Prevention of Venous Thromboembolism after Total Hip or Knee Replacement.

This multicenter randomized comparative-effectiveness noninferiority trial compared 30 days of aspirin, warfarin, or rivaroxaban for VTE prophylaxis after elective total hip or knee arthroplasty.

N Engl J MedNov 12, 2026Read summary
Clinical ResearchAnesthesiology

Effect of discontinuing antihypertensives on perioperative hypotension in older patients before non-cardiac surgery: multicentre, randomised, double blind, controlled trial.

This multicentre, randomised, double blind, placebo controlled trial assessed whether withholding ACE inhibitors or ARBs on the morning of surgery reduces perioperative hypotension in older adults undergoing non-cardiac…

BMJNov 11, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.